BUPIVACAINE Side Effects

6501986-1 | Chondrolysis
on Sep 23, 2009 Male patient from UNITED STATES , 26 years of age, was diagnosed with arthroscopy and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: chondrolysis. Bupivacaine dosage: At Least 20 Cc.

6499023-0 | Chondrolysis
Patient was taking Bupivacaine (View Usage). Patient had the following side effects: chondrolysis on Sep 23, 2009 from UNITED STATES Additional patient health information: Male patient , 27 years of age, was diagnosed with arthroscopy and. Bupivacaine dosage: At Least 20 Cc.

6499017-5 | Chondrolysis
Adverse event was reported on Sep 23, 2009 by a Male patient taking Bupivacaine (View Usage) (Dosage: At Least 20 Cc) was diagnosed with arthroscopy and. Location: UNITED STATES , 33 years of age, After Bupivacaine was administered, patient had the following side effects: chondrolysis.

6497455-8 | Cardio-respiratory Arrest, Convulsion
on Dec 10, 2009 Female patient from UNITED STATES , 47 years of age, was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, convulsion. Bupivacaine dosage: . During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.


6477751-0 | Chondrolysis, Joint Range Of Motion Decreased, Pain
on Dec 03, 2009 Male patient from UNITED STATES , 23 years of age, was diagnosed with musculoskeletal pain and was treated with Bupivacaine (View Usage). Patient had the following side effects: chondrolysis, joint range of motion decreased, pain (What is pain?). Bupivacaine dosage: . Patient was hospitalized and became disabled.

6463890-7 | Spinal Cord Ischaemia
Patient was taking Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: spinal cord ischaemia on Nov 25, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, . Bupivacaine dosage: . During the same period patient was treated with KENALOG (View Kenalog Review and Kenalog Label ).

6456843-6 | Malnutrition
Adverse event was reported on Oct 08, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), nausea (What is nausea?), hypersensitivity, laxative supportive care and. Location: UNITED KINGDOM , weighting 89.73 lb, Patient experienced the following unwanted or unexpected effects: malnutrition. During the same period patient was treated with CLONIDINE (159.87 Mcg/ml) (View Clonidine Review and Clonidine Label ), ZICONOTIDE (View Ziconotide Review and Ziconotide Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), CHLORPHENIRAMINE (View Chlorpheniramine Review and Chlorpheniramine Label ), DOCUSATE (View Docusate Review and Docusate Label ). Patient was hospitalized.

6456253-1 | Eye Movement Disorder
on Nov 24, 2009 Male patient from UNITED STATES , 68 years of age, was diagnosed with cataract (What is cataract?) and was treated with Bupivacaine (View Usage). Patient had the following side effects: eye movement disorder. Bupivacaine dosage: 10 Ml Buffer 1 Dose. During the same period patient was treated with LIDOCAINE (10 Ml Buffer 1 Dose) (View Lidocaine Review and Lidocaine Label ).

6382381-5 | Device Leakage, Horner's Syndrome, Post Procedural Complication
on Sep 18, 2009 Female patient from UNITED STATES , 58 years of age, weighting 119.0 lb, was diagnosed with local anaesthesia and was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: device leakage, horner's syndrome, post procedural complication. Bupivacaine dosage: 450 Ml At A Rate Of 3 Ml/h, Extrapleural, Other. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6380686-5 | Atrioventricular Block Complete
Patient was taking Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete on Sep 17, 2009 from UNITED STATES Additional patient health information: Female patient , 78 years of age, weighting 130.1 lb, . Bupivacaine dosage: .

6379289-8 | Unresponsive To Stimuli
Adverse event was reported on Sep 23, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: 0.05% (6/4/10) Prn) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: unresponsive to stimuli. During the same period patient was treated with PERCOCET (2 Tabs Po X1) (View Percocet Review and Percocet Label ), SENNA (View Senna Review and Senna Label ), COLACE (View Colace Review and Colace Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TORADOL (View Toradol Review and Toradol Label ), NICOTINE (View Nicotine Review and Nicotine Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ANCEF (View Ancef Review and Ancef Label ).

6374481-0 | Meningitis Chemical
on Sep 15, 2009 Female patient from INDIA , 28 years of age, was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: meningitis chemical. Bupivacaine dosage: . During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ).

6366730-X | Loss Of Consciousness, Paralysis, Pupil Fixed, Respiration Abnormal
on Sep 16, 2009 Male patient from UNITED KINGDOM , 66 years of age, was diagnosed with induction of anaesthesia, induction and maintenance of anaesthesia, neuromuscular blockade reversal and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, paralysis (What is paralysis?), pupil fixed, respiration abnormal. Bupivacaine dosage: . During the same period patient was treated with TEMAZEPAM (View Temazepam Review and Temazepam Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), GLYCOPYRROLATE (View Glycopyrrolate Review and Glycopyrrolate Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ). Patient was hospitalized and became disabled.

6355127-4 | Colonic Pseudo-obstruction, Intestinal Obstruction
Patient was taking Bupivacaine (View Usage). Patient had the following side effects: colonic pseudo-obstruction, intestinal obstruction on Sep 09, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, . Bupivacaine dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ).

6347588-1 | Anaesthetic Complication, Blood Pressure Decreased, Heart Rate Decreased
Adverse event was reported on Sep 09, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia and. Location: UNITED STATES , 20 years of age, weighting 131.2 lb, After Bupivacaine was administered, patient had the following side effects: anaesthetic complication, blood pressure decreased, heart rate decreased. During the same period patient was treated with BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE (View Bupivacaine Hydrochloride And Epinephrine Review and Bupivacaine Hydrochloride And Epinephrine Label ).

6342160-1 | Convulsion
on Sep 04, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with preoperative care and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Bupivacaine dosage: 35 Ml Once. During the same period patient was treated with FENTANYL (50 Mcg Once) (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

6341678-5 | Anaesthetic Complication
on Sep 02, 2009 Female patient from UNITED STATES , 63 years of age, weighting 207.2 lb, was treated with Bupivacaine (View Usage). Patient had the following side effects: anaesthetic complication. Bupivacaine dosage: 11 Mg.

6305389-4 | Dyspnoea, Horner's Syndrome, Hypoglossal Nerve Paresis, Nasal Congestion, Nausea, Trigeminal Nerve Paresis
Patient was taking Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: dyspnoea, horner's syndrome, hypoglossal nerve paresis, nasal congestion, nausea (What is nausea?), trigeminal nerve paresis on Jul 28, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 34 years of age, was diagnosed with epidural anaesthesia and. Bupivacaine dosage: . During the same period patient was treated with FENTANYL (12ml Of 0.1% Bupivacaine With Fentanyl 2 Mcg/ml (12ml/hour)) (View Fentanyl Review and Fentanyl Label ).

6283787-5 | Complex Partial Seizures
Adverse event was reported on Jul 17, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: ) was diagnosed with anaesthesia procedure, convulsion and. Location: UNITED STATES , child 6 years of age, Patient experienced the following unwanted or unexpected effects: complex partial seizures. During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ).

6283782-6 | Complex Partial Seizures
on Jul 17, 2009 Male patient from UNITED STATES , 61 years of age, was diagnosed with postoperative analgesia, convulsion and was treated with Bupivacaine (View Usage). Patient had the following side effects: complex partial seizures. Bupivacaine dosage: . During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

6269774-1 | Fall, Malignant Neoplasm Progression
on Jul 10, 2009 Male patient from SWEDEN , weighting 79.37 lb, was diagnosed with lung neoplasm malignant, vomiting, gastritis, constipation (What is constipation?), hypokalaemia and was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: fall (What is fall?), malignant neoplasm progression. Bupivacaine dosage: 0.8 Mg/hour. During the same period patient was treated with MORPHINE (0.16 Mg/hour) (View Morphine Review and Morphine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), BETAMETASONE (View Betametasone Review and Betametasone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MACROGOL (View Macrogol Review and Macrogol Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6254075-8 | Dysuria, Foaming At Mouth, Headache, Hyperhidrosis, Peripheral Coldness, Procedural Pain
Patient was taking Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: dysuria, foaming at mouth, headache (What is headache?), hyperhidrosis, peripheral coldness, procedural pain on Jun 30, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 310.0 lb, was diagnosed with procedural pain and. Bupivacaine dosage: Automatic Pump. During the same period patient was treated with OXYCODONE (As Needed Po) (View Oxycodone Review and Oxycodone Label ).

6249984-X | Blood Pressure Increased, Dizziness, Feeling Abnormal, Hallucination, Visual, Memory Impairment
Adverse event was reported on Jun 16, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: 5 Ml, Injection) was diagnosed with pain management, neck pain and. Location: UNITED STATES , 57 years of age, weighting 240.0 lb, Patient had the following side effects: blood pressure increased, dizziness (What is dizziness?), feeling abnormal, hallucination, visual, memory impairment. During the same period patient was treated with ISOVUE 128 (1 Ml, Epidural) (View Isovue-128 Review and Isovue-128 Label ), KENALOG 40 (80 Mg, Epidural) (View Kenalog-40 Review and Kenalog-40 Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), BENZYLHYDROCHLORTHIAZIDE (View Benzylhydrochlorthiazide Review and Benzylhydrochlorthiazide Label ).

6249980-2 | Blood Pressure Systolic Decreased, Cardio-respiratory Arrest, Feeling Abnormal, Heart Rate Decreased, Hypoaesthesia, Unresponsive To Stimuli
on Jun 16, 2009 Female patient from UNITED STATES , 54 years of age, weighting 149.9 lb, was diagnosed with pain management and was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: blood pressure systolic decreased, cardio-respiratory arrest, feeling abnormal, heart rate decreased, hypoaesthesia, unresponsive to stimuli. Bupivacaine dosage: Injection. During the same period patient was treated with ISOVUE 128 (One Time, Epidural) (View Isovue-128 Review and Isovue-128 Label ), KENALOG 40 (One Time, Epidural) (View Kenalog-40 Review and Kenalog-40 Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PERCOCET (View Percocet Review and Percocet Label ).

6241046-0 | Product Substitution Issue
on Jun 19, 2009 Female patient from UNITED STATES , 36 years of age, weighting 180.8 lb, was diagnosed with caesarean section and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: product substitution issue. Bupivacaine dosage: 1.8 M Intrathecal.

6217473-4 | Product Quality Issue
Patient was taking Bupivacaine (View Usage). Patient had the following side effects: product quality issue on Jun 04, 2009 from UNITED STATES Additional patient health information: Female patient , 30 years of age, weighting 90.00 lb, was diagnosed with spinal anaesthesia and. Bupivacaine dosage: 13.5 Mg Once It.

6214582-0 | Paraplegia
Adverse event was reported on May 04, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: ) was diagnosed with spinal anaesthesia, autoimmune thyroiditis and. Location: MOROCCO , 32 years of age, After Bupivacaine was administered, patient had the following side effects: paraplegia. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

6211864-3 | Anaemia Postoperative, Burning Sensation, Movement Disorder, Paraesthesia, Phantom Pain, Post Procedural Haemorrhage, Sensory Loss
on May 18, 2009 Male patient from TAIWAN, PROVINCE OF CHINA , 68 years of age, weighting 138.9 lb, was diagnosed with spinal anaesthesia and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia postoperative, burning sensation, movement disorder (What is movement disorder?), paraesthesia, phantom pain, post procedural haemorrhage, sensory loss. Bupivacaine dosage: 10 Mg, Intraspinal.

6209688-6 | Horner's Syndrome, Hypoglossal Nerve Disorder, Trigeminal Nerve Disorder
on May 28, 2009 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with epidural anaesthesia and was treated with Bupivacaine (View Usage). Patient had the following side effects: horner's syndrome, hypoglossal nerve disorder, trigeminal nerve disorder. Bupivacaine dosage: . During the same period patient was treated with FENTANYL (2 Ug/ml) (View Fentanyl Review and Fentanyl Label ), OXYTOCIN (View Oxytocin Review and Oxytocin Label ).

6208543-5 | Confusional State, Overdose, Restlessness
Patient was taking Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: confusional state, overdose, restlessness on May 25, 2009 from NORWAY Additional patient health information: Female patient , 36 years of age, was diagnosed with local anaesthesia and. Bupivacaine dosage: . During the same period patient was treated with XYLOCAINE (Cumulative Dose Until Onset Of First Adverse Reaction 1200 Mg) (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

6188734-2 | Paraplegia
Adverse event was reported on May 04, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: ) was diagnosed with spinal anaesthesia, autoimmune thyroiditis and. Location: MOROCCO , 32 years of age, Patient experienced the following unwanted or unexpected effects: paraplegia. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

6188377-0 | Cardiomyopathy
on May 07, 2009 Female patient from KOREA, REPUBLIC OF , 48 years of age, was diagnosed with anaesthesia and was treated with Bupivacaine (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Bupivacaine dosage: . Patient was hospitalized.

6164873-7 | Meningitis Bacterial
on Apr 14, 2009 Male patient from ETHIOPIA , 26 years of age, was diagnosed with spinal anaesthesia and was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: meningitis bacterial. Bupivacaine dosage: . Patient was hospitalized.

6161638-7 | Bone Lesion, Chondrolysis, Fall, Injury, Musculoskeletal Pain
Patient was taking Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: bone lesion, chondrolysis, fall (What is fall?), injury, musculoskeletal pain on Apr 09, 2009 from UNITED STATES Additional patient health information: Male patient , 19 years of age, was diagnosed with musculoskeletal pain and. Bupivacaine dosage: Intra-articular. During the same period patient was treated with MARCAINE HYDROCHLORIDE W/ EPINEPHRINE (Intra-articular) (View Marcaine Hydrochloride W/ Epinephrine Review and Marcaine Hydrochloride W/ Epinephrine Label ), LIDOCAINE (Intra-articular) (View Lidocaine Review and Lidocaine Label ), SORENSON MEDICAL PAIN PUMP (View Sorenson Medical Pain Pump Review and Sorenson Medical Pain Pump Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), ANCEF (View Ancef Review and Ancef Label ).

6155861-5 | Atrial Flutter, Blood Pressure Decreased
Adverse event was reported on Apr 06, 2009 by a Male patient taking Bupivacaine (View Usage) (Dosage: ) was diagnosed with nerve block and. Location: UNITED STATES , weighting 18.74 lb, Patient had the following side effects: atrial flutter, blood pressure decreased. Patient was hospitalized.

6155631-8 | Electrocardiogram St Segment Depression, Electrocardiogram T Wave Inversion, Ventricular Dysfunction
on Apr 06, 2009 Male patient from UNITED STATES , weighting 27.12 lb, was diagnosed with nerve block and was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: electrocardiogram st segment depression, electrocardiogram t wave inversion, ventricular dysfunction. Bupivacaine dosage: . Patient was hospitalized.

6146654-3 | Anaesthetic Complication, Muscular Weakness, Neuromuscular Block Prolonged
on Apr 03, 2009 Male patient from UNITED STATES , 77 years of age, weighting 170.5 lb, was diagnosed with spinal anaesthesia and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication, muscular weakness, neuromuscular block prolonged. Bupivacaine dosage: Once Other.

6146653-1 | Anaesthetic Complication
Patient was taking Bupivacaine (View Usage). Patient had the following side effects: anaesthetic complication on Apr 03, 2009 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 168.0 lb, was diagnosed with spinal anaesthesia and. Bupivacaine dosage: Once Other. Patient was hospitalized.

6133251-9 | Soft Tissue Necrosis
Adverse event was reported on Mar 17, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: 3 Ml/h) was diagnosed with metastases to spine and. Location: SWITZERLAND , 74 years of age, weighting 112.0 lb, After Bupivacaine was administered, patient had the following side effects: soft tissue necrosis. During the same period patient was treated with MORPHIN (3 Ml/h) (View Morphin Review and Morphin Label ), CLONIDINE (3 Ml/h) (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6124423-8 | Post Lumbar Puncture Syndrome
on Mar 11, 2009 Male patient from TURKEY , 37 years of age, was diagnosed with anaesthesia and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: post lumbar puncture syndrome. Bupivacaine dosage: 6 Mg Of 5 Mg Ml-1. During the same period patient was treated with FENTANYL 25 (10 Ug Of Fentanyl In 0.2 Ml) (View Fentanyl-25 Review and Fentanyl-25 Label ), MAGNESIUM SULFATE (50 Mg Magnesium In 3 Ml Of 0.9 % Sodium Chloride) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), SODIUM CHLORIDE (15 - 20 Mg.kg) (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

6110928-2 | Subdural Haematoma
on Mar 02, 2009 Female patient from ITALY , 36 years of age, was diagnosed with analgesia and was treated with Bupivacaine (View Usage). Patient had the following side effects: subdural haematoma. Bupivacaine dosage: . During the same period patient was treated with LEVOBUPIVACAINE (View Levobupivacaine Review and Levobupivacaine Label ), SUFENTANIL (Spinal Space) (View Sufentanil Review and Sufentanil Label ).

6098067-0 | Diplegia, Neuromuscular Block Prolonged
Patient was taking Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: diplegia, neuromuscular block prolonged on Feb 20, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 27 years of age, was diagnosed with spinal anaesthesia, postoperative analgesia and. Bupivacaine dosage: . During the same period patient was treated with SALINE (2ml Mixed With Bupivacaine) (View Saline Review and Saline Label ), DIAMORPHINE (500mcg) (View Diamorphine Review and Diamorphine Label ). Patient was hospitalized.

6084046-6 | Diplegia, Neuromuscular Block Prolonged
Adverse event was reported on Feb 10, 2009 by a Female patient taking Bupivacaine (View Usage) (Dosage: ) was diagnosed with spinal anaesthesia, postoperative analgesia and. Location: UNITED KINGDOM , 27 years of age, Patient experienced the following unwanted or unexpected effects: diplegia, neuromuscular block prolonged. During the same period patient was treated with SALINE (2ml Mixed With Bupivacaine) (View Saline Review and Saline Label ), DIAMORPHINE (500mcg) (View Diamorphine Review and Diamorphine Label ). Patient was hospitalized.

6083933-2 | Chondrolysis, Fall, Joint Injury, Joint Instability, Joint Sprain, Rotator Cuff Syndrome, Tendon Rupture
on Feb 05, 2009 Male patient from UNITED STATES , 19 years of age, was diagnosed with musculoskeletal pain and was treated with Bupivacaine (View Usage). Patient had the following side effects: chondrolysis, fall (What is fall?), joint injury, joint instability, joint sprain, rotator cuff syndrome, tendon rupture. Bupivacaine dosage: Intra-articular. During the same period patient was treated with MARCAINE HCL W/ EPINEPHRINE (Bolus, Intra-articular) (View Marcaine Hcl W/ Epinephrine Review and Marcaine Hcl W/ Epinephrine Label ), LIDOCAINE (Intra-articular) (View Lidocaine Review and Lidocaine Label ), SORENSON MEDICAL PAIN PUMP (View Sorenson Medical Pain Pump Review and Sorenson Medical Pain Pump Label ).

6016260-X | Tachycardia
on Dec 17, 2008 Female patient from IRELAND , 52 years of age, was diagnosed with epidural anaesthesia and was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: tachycardia. Bupivacaine dosage: Bolus Of 10 Ml Of 0.25 % Bupivacaine. During the same period patient was treated with FENTANYL 100 (Bolus Of 5 Ug/ml) (View Fentanyl-100 Review and Fentanyl-100 Label ), FENTANYL 100 (2 Ug/ml) (View Fentanyl-100 Review and Fentanyl-100 Label ), FENTANYL 100 (16 Mg/hr) (View Fentanyl-100 Review and Fentanyl-100 Label ). Patient was hospitalized.

5978675-5 | Chondrolysis
Patient was taking Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: chondrolysis on Nov 26, 2008 from UNITED STATES Additional patient health information: Female patient , 18 years of age, was diagnosed with arthroscopy and. Bupivacaine dosage: Preinjection With Epinephrine.

5976203-1 |
Adverse event was reported on Nov 26, 2008 by a Female patient taking Bupivacaine (View Usage) (Dosage: ) . Location: UNITED STATES , 16 years of age, . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ).

5939647-X | Anxiety, Constipation, Dizziness, Dysuria, Fear, Gait Disturbance, Headache, Insomnia, Muscular Weakness
on Oct 30, 2008 Female patient from UNITED STATES , 52 years of age, weighting 140.0 lb, was diagnosed with back pain (What is back pain?), intervertebral disc disorder and was treated with Bupivacaine (View Usage). After Bupivacaine was administered, patient had the following side effects: anxiety (What is anxiety?), constipation (What is constipation?), dizziness (What is dizziness?), dysuria, fear, gait disturbance, headache (What is headache?), insomnia, muscular weakness. Bupivacaine dosage: .

5918112-X | Colon Cancer, Myocardial Ischaemia
on Oct 02, 2008 Male patient from UNITED KINGDOM , weighting 218.3 lb, was diagnosed with pain (What is pain?), fluid retention, myocardial ischaemia, urinary tract infection (What is urinary tract infection?) and was treated with Bupivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer, myocardial ischaemia. Bupivacaine dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOSARTAN (View Losartan Review and Losartan Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ).

5917921-0 | Dizziness, Foaming At Mouth, Grand Mal Convulsion, Ventricular Fibrillation
Patient was taking Bupivacaine (View Usage). Patient had the following side effects: dizziness (What is dizziness?), foaming at mouth, grand mal convulsion, ventricular fibrillation on Oct 07, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 30 years of age, was diagnosed with epidural anaesthesia, haemorrhage and. Bupivacaine dosage: . During the same period patient was treated with GELOFUSIN (View Gelofusin Review and Gelofusin Label ), SYNTOCINON (View Syntocinon Review and Syntocinon Label ). Patient was hospitalized.